[Form 4] AUDIOEYE INC Insider Trading Activity
Rhea-AI Filing Summary
Katherine E. Fleming, a Director of AudioEye, Inc. (AEYE), reported a non‑derivative transaction on 10/01/2025 showing receipt of 867 restricted stock units (RSUs) granted under the 2020 Equity Incentive Plan. The RSUs are reported with a transaction code indicating a grant (Code A) and a reported price of $0. Following the grant, Ms. Fleming beneficially owns 33,794 shares. The RSUs vested on the grant date and will be settled upon the earlier of the third anniversary of the grant, immediately prior to closing of a change in control (but no later than 90 days after such change), or in the calendar year following death (with payment by year‑end). The Form 4 was signed by an attorney‑in‑fact on 10/03/2025.
Positive
- 867 RSUs granted to Director Katherine E. Fleming, indicating board alignment with equity incentives
- RSUs vested on grant date, providing immediate alignment of director equity interests
- Beneficial ownership increased to 33,794 shares, disclosed clearly
Negative
- None.
Insights
Director received time‑based RSUs that vested immediately and will settle under defined conditions.
The filing shows a one‑time grant of 867 RSUs to Director Katherine E. Fleming that vested on the grant date, which is explicit in the explanation. Immediate vesting of RSUs is a concrete governance event tied to compensation policy rather than performance metrics.
This matters because immediate vesting changes the timing of potential dilution and aligns the director's equity stake—now 33,794 shares beneficially owned—with ownership disclosure rules. The settlement timing provisions (third anniversary or change in control conditions) are contractual and limit when shares transfer.
RSU grant is non‑cash compensation with clear settlement and vesting terms.
The RSUs were granted under the 2020 Equity Incentive Plan and reported at $0, indicating restricted units rather than a cash purchase. The filing explicitly states settlement triggers: third anniversary, prior to a change in control (with a 90‑day cap), or the calendar year after death.
This is important for shareholders because the grant increases the director’s reported beneficial ownership to 33,794 shares and defines when those units convert to common stock for voting and economic purposes.